Rituximab reduces the incidence of acute graft-versus-host disease

被引：33

作者：

Christopeit, Maximilian ^{[1
]}

Schuettee, Vincent ^{[1
]}

Theurich, Sebastian ^{[1
]}

Weber, Thomas ^{[1
]}

Grothe, Wilfried ^{[1
]}

Behre, Gerhard ^{[1
]}

机构：

[1] Univ Hosp Halle Saale, Dept Internal Med 4, D-06097 Halle, Germany

来源：

BLOOD | 2009年 / 113卷 / 13期

关键词：

STEM-CELL TRANSPLANTATION; ANTIGEN-PRESENTING CELLS;

D O I：

10.1182/blood-2009-01-200527

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3130 / 3131

页数：2

共 10 条

[1] Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ [J].

Anderson, BE ;

McNiff, JM ;

Jain, D ;

Blazar, BR ;

Shlomchik, WD ;

Shlomchik, MJ .

BLOOD, 2005, 105 (05) :2227-2234

[2] Rituximab for steroid-refractory chronic graft-versus-host disease [J].

Cutler, Corey ;

Miklos, David ;

Kim, Haesook T. ;

Treister, Nathaniel ;

Woo, Sook-Bin ;

Bienfang, Don ;

Klickstein, Lloyd B. ;

Levin, Jesse ;

Miller, Katherine ;

Reynolds, Carol ;

Macdonell, Rebecca ;

Pasek, Mildred ;

Lee, Stephanie J. ;

Ho, Vincent ;

Soiffer, Robert ;

Antin, Joseph H. ;

Ritz, Jerome ;

Alyea, Edwin .

BLOOD, 2006, 108 (02) :756-762

[3] Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [J].

Edwards, JCW ;

Szczepanski, L ;

Szechinski, J ;

Filipowicz-Sosnowska, A ;

Emery, P ;

Close, DR ;

Stevens, RM ;

Shaw, T .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) :2572-2581

[4]

Glass B, 2008, BLOOD, V112, P689

[5] B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis [J].

Hauser, Stephen L. ;

Waubant, Emmanuelle ;

Arnold, Douglas L. ;

Vollmer, Timothy ;

Antel, Jack ;

Fox, Robert J. ;

Bar-Or, Amit ;

Panzara, Michael ;

Sarkar, Neena ;

Agarwal, Sunil ;

Langer-Gould, Annette ;

Smith, Craig H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (07) :676-688

[6] B-Cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation [J].

Iori, Anna P. ;

Torelli, Giovanni F. ;

De Propris, Maria S. ;

Milano, Filippo ;

Pupella, Simonetta ;

Gozzer, Maria ;

Mancini, Francesca ;

Milani, Maria L. ;

Intoppa, Stefania ;

Cerretti, Raffaella ;

Lucarelli, Barbarella ;

Valle, Veronica ;

Malandruccolo, Luigi ;

Iannella, Emilia ;

Arleo, Eva ;

Guarini, Anna ;

Foa, Robin .

TRANSPLANTATION, 2008, 85 (03) :386-390

[7] Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia [J].

Kebriaei, P. ;

Saliba, R. M. ;

Ma, C. ;

Ippoliti, C. ;

Couriel, D. R. ;

de Lima, M. ;

Giralt, S. ;

Qazilbash, M. H. ;

Gajewski, J. L. ;

Ha, C. S. ;

Champlin, R. E. ;

Khouri, I. F. .

BONE MARROW TRANSPLANTATION, 2006, 38 (03) :203-209

[8] Donor APCs are required for maximal GVHD but not for GVL [J].

Matte, CC ;

Liu, JL ;

Cormier, J ;

Anderson, BE ;

Athanasiadis, I ;

Jain, D ;

McNiff, J ;

Shlomchik, W .

NATURE MEDICINE, 2004, 10 (09) :987-992

[9] Prevention of graft versus host disease by inactivation of host antigen-presenting cells [J].

Shlomchik, WD ;

Couzens, MS ;

Tang, CB ;

McNiff, J ;

Robert, ME ;

Liu, JL ;

Shlomchik, MJ ;

Emerson, SG .

SCIENCE, 1999, 285 (5426) :412-415

[10] Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab [J].

Tokunaga, M ;

Fujii, K ;

Saito, K ;

Nakayamada, S ;

Tsujimura, S ;

Nawata, M ;

Tanaka, Y .

RHEUMATOLOGY, 2005, 44 (02) :176-182

← 1 →